Robyn Sierla, BAppSc (OT), is an occupational therapist in the Occupational Therapy Department at Royal Prince Alfred Hospital in Camperdown; Teresa Sze Mun Lee, PhD, BAppSc (Physio) (Hons), is a lymphedema physiotherapist at Royal North Shore Hospital in St. Leonards; and Deborah Black, PhD, MStat, DipEd, BSc, is an associate dean of staff development and Sharon Lynn Kilbreath, PhD, MClSc, BSc (Physio), is a National Breast Cancer Foundation Research Fellow and a member of the Faculty of Health Sciences, both at the University of Sydney in Lidcombe, all in New South Wales, Australia. The authors take full responsibility for the content of the article. The authors did not receive honoraria for this work. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the authors, planners, independent peer reviewers, or editorial staff. Kilbreath can be reached at sharon.kilbreath@sydney.edu.au, with copy to editor at CJONEditor @ons.org. ymphedema is a chronic condition that can occur following treatment for breast cancer. Although the mechanism is not fully understood, lymphedema can be progressive. Initially, swelling is caused by interstitial accumulation of fluids and plasma proteins, which is followed by increased deposition of adipose tissue and connective tissue, as well as an increase in numbers of fibroblasts and neutrophils (Jensen, Simonsen, Karlsmark, & Bulow, 2010) . Size and shape distortions of affected areas, increased risk of infection, skin changes, discomfort, and psychosocial impacts all can be significant for those with lymphedema (International Consensus, 2006) . Treatment for lymphedema aims to reduce the amount of fluid and prevent additional accumulation, with the ultimate goal of halting or reversing the effects. International guidelines recommend compression, massage, skin care, © iStockphoto.com/peepo exercise, and elevation to treat lymphedema. In addition, surgical, pharmacologic, complementary and alternative medicines (CAMs), and other interventions are used (Hayes, 2008; International Consensus, 2006; Moseley, Carati, & Piller, 2007) . However, research into the efficacy of those modalities generally has been of poor methodologic quality and limited in focus (Badger, Preston, Seers, & Mortimer, 2004; Karki, Anttila, Tasmuth, & Rautakorpi, 2009 ). In addition, attention to symptomatic relief is lacking, with outcome measures reported only on the physical changes (Devoogdt et al., 2011; Karki et al., 2009; Torres Lacomba et al., 2010) . Research also is limited on the management of lymphedema in the chest wall or breast region, which can present secondary to treatment of breast cancer.
Because of the paucity of high-quality studies in this area, the aim of the current study was to (a) describe the magnitude
